Medical Device Reportability Assessment & MDR Reporting Support
Get expert support for medical device reportability decisions, MDR submissions, and post-market complaint governance. Elexes helps manufacturers assess adverse events, document defensible rationales, and meet FDA and global vigilance timelines with confidence. Our team integrates reportability reviews with complaint handling, PMS, risk management, and quality system expectations to reduce compliance risk.
Our Reportability Assessment & MDR Reporting Support Services
Targeted post-market regulatory support for complaint review, reportability decisions, MDR drafting, and ongoing compliance governance.
Reportability Support
Structured evaluation of complaints, malfunctions, and adverse events against FDA MDR and other vigilance criteria, with documented rationale that supports timely, defensible reporting decisions.
Complaint Governance
Oversight for complaint intake, classification, investigation quality, closure documentation, and escalation pathways so post-market records support both compliance and patient safety obligations.
PMS Support
Post-market surveillance support that connects complaint trends, literature, field feedback, and safety signals to PMS reports, risk files, CAPA actions, and ongoing regulatory obligations.
Agency Response
Support for responding to regulatory authority questions, deficiency items, and follow-up requests related to adverse event reporting, complaint handling, and post-market compliance records.
Change Assessments
Documented regulatory impact assessments for device, labeling, software, or process changes that may affect reportability obligations, post-market risk profiles, or submission requirements.
Virtual RAQA Support
Embedded RAQA operational support for manufacturers needing ongoing help with reportability workflows, complaint systems, document control, and broader post-market quality governance.
Post-Market Compliance Support
Defensible MDR Decisions Without Delays
Medical device reportability decisions carry high regulatory stakes. Elexes helps manufacturers evaluate complaints, malfunctions, and adverse events against applicable MDR criteria, document clear decision rationales, and prepare accurate submissions on time. Our support strengthens consistency across complaint handling, post-market surveillance, CAPA, and risk management so your organization can respond quickly without sacrificing regulatory defensibility.
Trusted By Manufacturers
Success Stories
See how manufacturers rely on Elexes for accurate, timely, and defensible post-market regulatory support.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Manufacturers trust Elexes for disciplined regulatory judgment and practical post-market execution.
Deep Experience
50+ years of collective experience across medical device regulatory and quality functions.
Global Coverage
Support across FDA, Health Canada, EU, TGA, and other global reporting frameworks.
Integrated Governance
Reportability decisions are aligned with complaints, PMS, CAPA, and risk management records.
Proven Results
250+ successful projects and a 90% audit clearance rate support confident execution.
Meet The Elexes Team
Experienced regulatory specialists supporting complex post-market obligations.
Elexes is a trusted medical device regulatory consulting partner supporting manufacturers across the full product lifecycle, from development and submissions to post-market compliance. The team brings 50+ years of collective experience across regulatory affairs, quality systems, clinical documentation, and global market access. For reportability assessment and MDR reporting support, Elexes applies that cross-functional expertise to help clients make timely, defensible decisions on complaints, malfunctions, and adverse events. With experience spanning FDA, EU, TGA, Health Canada, and other frameworks, Elexes helps organizations build stronger complaint handling and surveillance systems while reducing the risk of missed deadlines, weak rationales, and avoidable regulatory exposure.
250+ ProjectsSuccessful regulatory and quality engagements completed.200+ Product TypesExperience across diverse device categories and technologies.90% Audit ClearanceStrong track record supporting inspection and audit readiness.
Frequently Asked Questions
What are the criteria for MDR reporting?
For FDA MDR reporting, a manufacturer generally must report when it becomes aware of information that reasonably suggests a device may have caused or contributed to a death or serious injury, or has malfunctioned in a way that would likely cause or contribute to a death or serious injury if it recurred. A proper assessment reviews event details, device involvement, seriousness, malfunction significance, and available investigation findings.
What is MDR reportability?
MDR reportability is the process of determining whether a complaint, adverse event, or device malfunction meets the legal threshold for submission under Medical Device Reporting requirements. It involves evaluating the facts of the event, the device’s role, patient outcome, recurrence risk, and applicable regulatory definitions. The goal is to produce a timely, documented, and defensible reporting decision supported by complaint and investigation records.
What information is needed to assess whether an event is reportable?
A sound assessment typically uses the complaint record, device identification, event narrative, patient outcome, investigation status, prior similar events, risk documentation, and any available clinical or technical evidence. Reviewers also check whether the event reflects a malfunction, labeling issue, use error, or product quality problem. Complete documentation is essential because reportability decisions must be justified clearly if reviewed during an inspection or audit.
How quickly should MDR reportability be evaluated?
Reportability should be evaluated as soon as a manufacturer becomes aware of potentially relevant information. Early triage is critical because complaint intake delays can compress statutory reporting timelines and weaken investigation quality. A disciplined process usually includes immediate intake review, prompt escalation of serious events, documented decision checkpoints, and follow-up when new facts emerge. Fast initial assessment helps preserve compliance even when investigations are still ongoing.
Can a malfunction be reportable even if no patient was harmed?
Yes. A malfunction can still be reportable if it would be likely to cause or contribute to a death or serious injury were it to recur. That means the assessment cannot stop at the absence of actual harm in the reported event. Reviewers must evaluate the device function, foreseeable recurrence, severity of potential outcome, and whether existing controls meaningfully reduce the risk.
How does complaint handling connect to MDR reporting?
Complaint handling is often the starting point for MDR decisions because complaints provide the intake pathway for adverse events, malfunctions, and field issues. A compliant system should classify complaints accurately, trigger timely investigations, escalate potentially reportable events, and maintain closure records that support the final rationale. Weak complaint governance can lead to missed reports, inconsistent decisions, poor trending, and inspection findings tied to post-market controls.
Do reportability decisions need to be documented when an event is not reported?
Yes. Non-report decisions should still be documented with a clear rationale, supporting facts, and references to the applicable criteria used in the assessment. Regulators and auditors often review these records to confirm that the manufacturer applies reportability standards consistently. A defensible file usually includes the event summary, seriousness evaluation, malfunction analysis, investigation status, and the reasoning behind why the event did not meet reporting thresholds.
Can Elexes support ongoing MDR reporting operations, not just one-time assessments?
Yes. Elexes supports both one-time reportability reviews and ongoing operational models through complaint governance, PMS support, virtual RAQA services, and regulatory outsourcing. That means manufacturers can get help with intake triage, decision documentation, MDR drafting, authority follow-up, trend review, and integration with CAPA and risk management. This is especially useful for teams managing growing complaint volumes or limited in-house RAQA capacity.
Still Need MDR Guidance?
Talk with our regulatory team about reportability decisions and reporting workflows.
Regions We Support
Elexes supports medical device manufacturers across major regulated markets with remote regulatory and post-market compliance services.
Global Markets
Service Reach
USA, UK, EU, Canada
Coverage
Remote & Embedded
Support Model
USA
UK
Europe
Canada
Australia
Asia
Hong Kong
California
Massachusetts
New York
Need Support In Your Market?
Ask about coverage for your device portfolio and reporting obligations.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise.
MDSAP
Supports multi-market audit readiness.
IEC 62304
Software lifecycle compliance knowledge.
